Vista 300/Vista 300 S +5 more— 510(k) K252250
Substantially EquivalentShanghai Draeger Medical Instrument Co., Ltd.
FDA 510(k) clearance K252250 for Vista 300/Vista 300 S +5 more, Substantially Equivalent on 2026-04-10. Applicant: Shanghai Draeger Medical Instrument Co., Ltd.. Device class: 2.
Summary
This filing covers the Vista 300 and Vista 300 S patient monitors in five US configurations, split between non-invasive and invasive models. Product code MHX is for physiological patient monitors with arrhythmia detection or alarms: the bedside monitors that show ECG, SpO2, blood pressure, and related vitals.
Class II, 21 CFR 870.1025. The Cardiovascular panel reviewed it as a Traditional 510(k).
The applicant is Shanghai Draeger Medical Instrument, the Chinese arm of Germany's Drägerwerk, filing from Shanghai. Review took 267 days (July 17, 2025 to April 10, 2026). Clearing every configuration of a monitor platform in one submission is common practice.
Clearance details
- Device name as filed
- Vista 300/Vista 300 S; Vista 300 Non-Inv Model A, US (2601064); Vista 300 Invasive Model C, US (2601065); Vista 300 S Non-Inv Model A, US (2602425); Vista 300 S Invasive Model B, US (2602426); Vista 300 S Invasive Model C, US (2602427)
- Applicant
- Shanghai Draeger Medical Instrument Co., Ltd.
- Product code
- Code MHX
- Device class
- Class 2
- Regulation
- 21 CFR 870.1025
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Shanghai, CN
Recent devices under product code MHX
view allMore clearances from Shanghai Draeger Medical Instrument Co., Ltd.
view allAdverse events under product code MHX
product code MHX- Death
- 580
- Injury
- 2,441
- Malfunction
- 12,655
- Other
- 3
- Total
- 15,679
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.